Advertisement

Index by author

June 01, 2004; Volume 32,Issue 6

A

  1. Anderton, Mark J.

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

  2. Anzenbacher, Pavel

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

  3. Arimori, Kazuhiko

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

B

  1. Baillie, Thomas A.

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

  2. Black, Virginia H.

    1. MOLECULAR CLONING OF THE GUINEA PIG CYP1A2 GENE 5′-FLANKING REGION: IDENTIFICATION OF FUNCTIONAL AROMATIC HYDROCARBON RESPONSE ELEMENT AND CHARACTERIZATION OF CYP1A2 EXPRESSION IN GPC16 CELLS
      Virginia H. Black and Linda C. Quattrochi
      Drug Metabolism and Disposition June 2004, 32 (6) 595-602; DOI: https://doi.org/10.1124/dmd.32.6.595

  3. Borlak, Jürgen

    1. ANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATS
      Jürgen Borlak, Ingo Schulte and Thomas Thum
      Drug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675

  4. Bridges, Alexander J.

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

  5. Buist, Susan C. N.

    1. RAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3; SLC22A6–8) mRNA LEVELS
      Susan C. N. Buist and Curtis D. Klaassen
      Drug Metabolism and Disposition June 2004, 32 (6) 620-625; DOI: https://doi.org/10.1124/dmd.32.6.620

C

  1. Cai, Xiaoxin

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

D

  1. Dean, Dennis C.

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

E

  1. Edom, Richard W.

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

  2. Evans, David C.

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

F

  1. Frandsen, H.

    1. IDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeAαC)
      H. Frederiksen and H. Frandsen
      Drug Metabolism and Disposition June 2004, 32 (6) 661-665; DOI: https://doi.org/10.1124/dmd.32.6.661

  2. Frederiksen, H.

    1. IDENTIFICATION OF METABOLITES IN URINE AND FECES FROM RATS DOSED WITH THE HETEROCYCLIC AMINE, 2-AMINO-3-METHYL-9H-PYRIDO[2,3-b]INDOLE (MeAαC)
      H. Frederiksen and H. Frandsen
      Drug Metabolism and Disposition June 2004, 32 (6) 661-665; DOI: https://doi.org/10.1124/dmd.32.6.661

  3. Fujita, Ken-ichi

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

G

  1. Gescher, Andreas

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

  2. Goosen, Theunis C.

    1. SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587

  3. Guengerich, F. Peter

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

  4. Gut, Ivan

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

H

  1. He, Kan

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

  2. Hidaka, Muneaki

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

  3. Hollenberg, Paul F.

    1. SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587

I

  1. Iwakiri, Tomomi

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

J

  1. Juntunen, Tarja

    1. SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

K

  1. Kent, Ute M.

    1. SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587

  2. Klaassen, Curtis D.

    1. RAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3; SLC22A6–8) mRNA LEVELS
      Susan C. N. Buist and Curtis D. Klaassen
      Drug Metabolism and Disposition June 2004, 32 (6) 620-625; DOI: https://doi.org/10.1124/dmd.32.6.620

  3. Kodama, Hirofumi

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

L

  1. Liu, Wensheng

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

M

  1. Mager, Donald E.

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

  2. Manson, Margaret M.

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

N

  1. Nieminen, Riina

    1. SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

O

  1. Obach, R. Scott

    1. VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
      Robert L. Walsky and R. Scott Obach
      Drug Metabolism and Disposition June 2004, 32 (6) 647-660; DOI: https://doi.org/10.1124/dmd.32.6.647

  2. Ogikubo, Tetsuya

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

  3. Okumura, Manabu

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581

P

  1. Pelkonen, Olavi

    1. SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

  2. Pool, William F.

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

Q

  1. Quattrochi, Linda C.

    1. MOLECULAR CLONING OF THE GUINEA PIG CYP1A2 GENE 5′-FLANKING REGION: IDENTIFICATION OF FUNCTIONAL AROMATIC HYDROCARBON RESPONSE ELEMENT AND CHARACTERIZATION OF CYP1A2 EXPRESSION IN GPC16 CELLS
      Virginia H. Black and Linda C. Quattrochi
      Drug Metabolism and Disposition June 2004, 32 (6) 595-602; DOI: https://doi.org/10.1124/dmd.32.6.595

R

  1. Raunio, Hannu

    1. SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

  2. Reed, Jessica E.

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

  3. Reily, Michael D.

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

  4. Rodrigues, A. David

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

S

  1. Schulte, Ingo

    1. ANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATS
      Jürgen Borlak, Ingo Schulte and Thomas Thum
      Drug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675

  2. Shou, Magang

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

  3. Simek, Petr

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

  4. Smith, Brian R.

    1. A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 603-611; DOI: https://doi.org/10.1124/dmd.32.6.603
    2. A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIME
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 612-619; DOI: https://doi.org/10.1124/dmd.32.6.612

  5. Soucek, Pavel

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

  6. Sridar, Chitra

    1. SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587

  7. Steward, William P.

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

  8. Svobodova, Lenka

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

T

  1. Taavitsainen, Päivi

    1. SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

  2. Talaat, Rasmy E.

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

  3. Thum, Thomas

    1. ANDROGEN METABOLISM IN THYMUS OF FETAL AND ADULT RATS
      Jürgen Borlak, Ingo Schulte and Thomas Thum
      Drug Metabolism and Disposition June 2004, 32 (6) 675-679; DOI: https://doi.org/10.1124/dmd.32.6.675

  4. Turpeinen, Miia

    1. SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
      Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
      Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

V

  1. Vaclavikova, Radka

    1. DIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
      Radka Vaclavikova, Pavel Soucek, Lenka Svobodova, Pavel Anzenbacher, Petr Simek, F. Peter Guengerich and Ivan Gut
      Drug Metabolism and Disposition June 2004, 32 (6) 666-674; DOI: https://doi.org/10.1124/dmd.32.6.666

  2. Verschoyle, Richard

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

W

  1. Walsky, Robert L.

    1. VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
      Robert L. Walsky and R. Scott Obach
      Drug Metabolism and Disposition June 2004, 32 (6) 647-660; DOI: https://doi.org/10.1124/dmd.32.6.647

  2. Wang, Regina W.

    1. VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES
      Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis C. Dean and Thomas A. Baillie
      Drug Metabolism and Disposition June 2004, 32 (6) 584-586; DOI: https://doi.org/10.1124/dmd.32.6.584

  3. Ward, Keith W.

    1. A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. I. CLEARANCE
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 603-611; DOI: https://doi.org/10.1124/dmd.32.6.603
    2. A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIME
      Keith W. Ward and Brian R. Smith
      Drug Metabolism and Disposition June 2004, 32 (6) 612-619; DOI: https://doi.org/10.1124/dmd.32.6.612

  4. Williams, J. Andrew

    1. SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
      Chitra Sridar, Theunis C. Goosen, Ute M. Kent, J. Andrew Williams and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2004, 32 (6) 587-594; DOI: https://doi.org/10.1124/dmd.32.6.587

  5. Williams, Marion L.

    1. PHYSIOLOGICAL MODELING OF FORMULATED AND CRYSTALLINE 3,3′-DIINDOLYLMETHANE PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION IN MICE
      Mark J. Anderton, Margaret M. Manson, Richard Verschoyle, Andreas Gescher, William P. Steward, Marion L. Williams and Donald E. Mager
      Drug Metabolism and Disposition June 2004, 32 (6) 632-638; DOI: https://doi.org/10.1124/dmd.32.6.632

  6. Woolf, Thomas F.

    1. METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED
      Kan He, Rasmy E. Talaat, William F. Pool, Michael D. Reily, Jessica E. Reed, Alexander J. Bridges and Thomas F. Woolf
      Drug Metabolism and Disposition June 2004, 32 (6) 639-646; DOI: https://doi.org/10.1124/dmd.32.6.639

Y

  1. Yamasaki, Keishi

    1. POTENT INHIBITION BY STAR FRUIT OF HUMAN CYTOCHROME P450 3A (CYP3A) ACTIVITY
      Muneaki Hidaka, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama and Kazuhiko Arimori
      Drug Metabolism and Disposition June 2004, 32 (6) 581-583; DOI: https://doi.org/10.1124/dmd.32.6.581
Back to top

In this issue